As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: June 19, 2012
by The Alzheimer’s Association:
Vision problems are a concern because more than sixty percent of individuals with Alzheimer’s will have a decline in some sort of visual capacity. Problems most often arise in four areas: motion blindness, depth perception, color perception, and contrast sensitivity.
Some people with Alzheimer’s are affected by motion blindness and are unable to sense movement. For these people they view the world as a series of still frames, rather than a “movie” that most people see. Doctors have theorized that this view of the world causes affected persons to become lost, even in familiar surroundings.
Persons with Alzheimer’s may also lose depth perception. Three-dimensional objects may begin to appear flat. This lack of perception could make shadows or a dark rug look like holes.
Many people will experience their color perception diminish as they age. However, persons with Alzheimer’s seem to experience a greater deficit of color perception, especially with colors in the blue-violet range.
The ability to see contrast between colors, not just the color itself, also is reduced in persons with Alzheimer’s. For example, if a bathroom has the same color toilet as the floor and walls, the person may have difficulty finding the toilet.
Tips for caregivers to help the individual with Alzheimer’s:
Source: Massachusetts Chapter newsletter
Napping for an hour in the afternoon may provide a mental boost for older adults, a new study suggests. This extra daytime sleep was linked to improved memory and ability to think clearly...
The results of recent trials that tested much-anticipated Alzheimer’s disease drugs dashed the hopes of patients with the debilitating condition. The most recent disappointment came from the large trial for solanezumab, by Eli Lilly, announced last...
Treatment with the antibiotic Rocephin (ceftriaxone) may restore brain function in areas affected by Alzheimer’s disease, according to new research. The study, “Mapping Synaptic Glutamate Transporter Dysfunction In Vivo To Regions Surrounding Aβ...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.